Measles immunisation in developing countriesBMJ 1994; 308 doi: https://doi.org/10.1136/bmj.308.6925.411b (Published 05 February 1994) Cite this as: BMJ 1994;308:411
- S K Obaro
- Department of Immunology, Chelsea and Westminister Hospital London SW10 9NH.
EDITOR, - Peter Aaby and colleagues raise issues about measles immunisation in developing countries that deserve comment and further evaluation.1 Measles before the age of 9 months remains an important problem in developing countries that was understated in the paper. In densely populated urban areas of west Africa the incidence may be as high as 30%.2 In a recent unpublished study of measles antibody levels in some 350 infants in Zaria, northern Nigeria, serological susceptibility …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial